Cipla to market Roche's Antibody Cocktail in India
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
The antibody cocktail is to be administered for the treatment of mild to moderate COVID-19
This marks Glenmark's first synthetic decapeptide injectable approval
BALflu is approved by DCGI for emergency use for the treatment of COVID-19
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis patients
I G Petrochemicals has reported total income of Rs.1126.94 crores during FY 2020-21
Balaji Amines has reported total income of Rs.1317.52 crores during FY 20-21
Consolidated revenue for the fourth quarter was up 26% YoY at Rs. 24,399 crore and EBITDA for Q4 FY21 surged 62% YoY to Rs. 5,142 crore
The companies are strengthening their collaboration in powder-based 3D printing
Grasim plans an investment in 200 TPD caustic brownfield expansion at Vilayat, Gujarat
Growing pragmatism about the safety of stocks in the chemical sector by top investment advisors stems from the fact that there is an increased demand in export markets and growth in specific Pharmaceutical segments
The acquisition of Chryso perfectly fits within Saint-Gobain’s strategic vision of worldwide leadership for sustainable construction
The deal is expected to close in June 2021
The company has reported total income of Rs.826.40 crores for FY 2020-21
The company has reported total income of Rs.760.74 crores for FY 2020-21
It posted net profit of Rs.188.77 crores for the period ended March 31, 2020.
The company plans to enter the EU markets in FY22
KPIC in Korea will benefit from technology's low operating, maintenance and investment costs
Nanoform and Celanese intend to work on formulation development, leveraging each organization's unique formulation expertise.
The unadjusted data show a 1.0% increase in May following a 0.9% gain in April.
Huntsman expects the offering to close on May 26, 2021, subject to customary closing conditions.
Subscribe To Our Newsletter & Stay Updated